News & AnalysisIsraeli biotech firm sparks investor interestXTL Pharmaceuticals will be the first Israeli biotechnology firm to list in London.ByPEI Staff29 December 2012•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.Middle EastMiddle East & North AfricaNorth AmericaWestern Europe